风险计算器预测完整降主动脉瘤TEVAR术后30天死亡率
本研究基于Vascular Quality Initiative数据库,纳入2014年8月至2020年8月因完整降主动脉瘤接受TEVAR的2141例患者,开发并内部验证了30天死亡率风险预测模型。90例(4.2%)在术后30天内死亡,模型纳入年龄≥75岁、冠心病、ASA IV/V级、手术紧迫性、既往颈动脉血运重建和近端锚定区<3等变量,AUC为0.75,内部验证偏倚校正AUC为0.73。该计算器有助于患者选择和术前讨论。
要点
- 年龄≥75岁、冠心病、ASA IV/V级、紧急/急诊手术、既往颈动脉血运重建和近端锚定区<3是30天死亡的独立预测因素。
- 模型区分度良好(AUC 0.75,内部验证偏倚校正AUC 0.73),校准良好(校准斜率1.00,截距0.00)。
- 在线TEVAR死亡率风险评分可辅助术前风险沟通和共同决策。
核心结论
- 开发了预测完整降主动脉瘤TEVAR术后30天死亡率的风险计算器,内部验证显示良好区分度和校准度。
研究设计与样本
- 回顾性多中心队列研究,查询Vascular Quality Initiative数据库,纳入2014年8月至2020年8月因完整降主动脉瘤接受TEVAR的2141例患者,行单变量和多变量分析开发30天死亡率风险评分,采用K折交叉验证和校准曲线进行内部验证。
主要发现
- 2141例患者中90例(4.2%)在术后30天内死亡。
- 多变量分析显示年龄≥75岁(OR 2.27;95%CI 1.50-3.44;P<.001)、冠心病(OR 1.60;95%CI 1.03-2.47;P=.036)、ASA IV/V级(OR 2.39;95%CI 1.39-4.10;P=.002)、紧急手术相对于择期(OR 3.47;95%CI 1.90-6.33;P<.001)、急诊手术相对于择期(OR 5.27;95%CI 2.36-11.75;P<.001)、既往颈动脉血运重建(OR 3.24;95%CI 1.64-6.39;P=.001)和近端锚定区<3(OR 2.51;95%CI 1.65-3.81;P<.001)与30天死亡率独立相关。
- 模型受试者工作特征曲线下面积为0.75,内部验证偏倚校正曲线下面积为0.73(95%CI 0.66-0.79),校准斜率为1.00,截距为0.00。
关键数值与推荐
- 风险评分变量包括:年龄≥75岁、冠心病、ASA IV/V级、手术紧迫性(紧急 vs 择期,急诊 vs 择期)、既往颈动脉血运重建、近端锚定区<3。
- 模型AUC 0.75,内部验证偏倚校正AUC 0.73(95%CI 0.66-0.79),校准斜率1.00,截距0.00。
临床怎么用
- 该风险计算器可用于完整降主动脉瘤TEVAR术前风险评估,辅助患者选择和共同决策。
- 在线版本TEVAR死亡率风险评分便于临床使用。
局限性
- 研究为回顾性数据库分析,仅进行内部验证,需外部验证确认泛化性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) for descending thoracic aortic aneurysm (DTAA) is associated with high perioperative survival, although mortality is a possible outcome. However, no risk score has been developed to predict mortality after TEVAR for intact DTAA to aid in risk discussion and preoperative patient selection. Our objective was to use a multi-institutional database to develop a 30-day mortality risk calculator for TEVAR after DTAA repair. METHODS: The Vascular Quality Initiative database was queried for patients treated with TEVAR for intact DTAA between August 2014 and August 2020. Univariable and multivariable analyses aided in developing a 30-day mortality risk score. Internal validation was done with K-fold cross-validation and calibration curve analysis. RESULTS: Of 2141 patients included in the analysis, 90 (4.2%) died within 30 days after the procedure. Clinically relevant variables identified to be independently associated with 30-day mortality and therefore used to derive the predictive model included age 75 years or greater (odds ratio [OR], 2.27; 95% confidence interval [CI], 1.50-3.44; P < .001), coronary artery disease (OR, 1.60; 95% CI, 1.03-2.47; P = .036), American Society of Anesthesiologists class IV/V (OR, 2.39; 95% CI, 1.39-4.10; P = .002), urgent vs elective procedure (OR, 3.47; 95% CI, 1.90-6.33; P < .001), emergent vs elective procedure (OR, 5.27; 95% CI, 2.36-11.75; P < .001), prior carotid revascularization (OR, 3.24; 95% CI, 1.64-6.39; P = .001), and proximal landing zone <3 (OR, 2.51; 95% CI, 1.65-3.81; P < .001). The model showed an area under the receiver operating characteristic curve of 0.75. Internal validation demonstrated a bias-corrected area under the receiver operating characteristic curve of 0.73 (95% CI, 0.66-0.79) and a calibration slope of 1.00 with a corresponding intercept of 0.00. CONCLUSIONS: This study provides a novel clinically relevant risk prediction model to estimate 30-day mortality risk after TEVAR for DTAA. The TEVAR Mortality Risk Calculator provides useful prognostic information to guide patient selection and facilitate preoperative discussions and shared decision making. An easily accessible online version of the TEVAR Mortality Risk Score is available to facilitate ease of use.
引用
- Naazie IN, Gupta JD, Azizzadeh A, et al. Risk calculator predicts 30-day mortality after thoracic endovascular aortic repair for intact descending thoracic aortic aneurysms in the Vascular Quality Initiative. J Vasc Surg. 2021. PMID: 34506896. doi:10.1016/j.jvs.2021.08.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。